These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4289320)

  • 1. Urinary pyrophosphate in normal subjects and in stone formers.
    O'Brien MM; Uhlemann I; McIntosh HW
    Can Med Assoc J; 1967 Jan; 96(2):100-3. PubMed ID: 4289320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in north-western India and the effect of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers.
    Sharma S; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1992; 48(4):404-8. PubMed ID: 1329300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a re-evaluation.
    Schwille PO; Rümenapf G; Wölfel G; Köhler R
    J Urol; 1988 Aug; 140(2):239-45. PubMed ID: 2840520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis.
    Conte A; Roca P; Genestar C; Grases F
    Urol Res; 1989; 17(3):173-5. PubMed ID: 2546315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical studies in paraplegic renal stone patients. 2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate.
    Burr RG; Nuseibeh I; Abiaka CD
    Br J Urol; 1985 Jun; 57(3):275-8. PubMed ID: 2988686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary calcium and phosphorus excretion and their relationship in calcium-containing urinary stone formers].
    Kitamura T; Moriyama N; Kawabe K; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):197-203. PubMed ID: 2747084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of influence of animal protein intake on the urinary risk factors of calcium oxalate stone formation].
    Nishii M
    Hinyokika Kiyo; 1984 Dec; 30(12):1737-47. PubMed ID: 6532203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the significance of the renal excretion of pyrophosphate].
    Gundlach G; Hoppe-Seyler GF; Dörr H; Bressel M
    Urologe; 1968; 7(1):56-61. PubMed ID: 4297581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis.
    Juuti M; Alhava EM; Lammi S
    Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
    Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
    Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.